QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
Log in
NASDAQ:GBT

Global Blood Therapeutics Earnings Date, Estimates & History

$43.85
+0.28 (+0.64 %)
(As of 11/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$43.26
Now: $43.85
$44.58
50-Day Range
$37.65
MA: $52.39
$63.77
52-Week Range
$36.49
Now: $43.85
$87.54
Volume596,706 shs
Average Volume1.00 million shs
Market Capitalization$2.71 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.77

Earnings

Global Blood Therapeutics (NASDAQ:GBT) Earnings Information

Global Blood Therapeutics last posted its earnings data on November 5th, 2020. The reported ($0.97) earnings per share for the quarter, missing the consensus estimate of ($0.72) by $0.25. The business earned $37 million during the quarter, compared to the consensus estimate of $44.56 million. Global Blood Therapeutics has generated ($4.71) earnings per share over the last year. Global Blood Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 24th, 2021 based off prior year's report dates.

Global Blood Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Global Blood Therapeutics (NASDAQ:GBT) Earnings Estimates

2020 EPS Consensus Estimate: ($4.52)
2021 EPS Consensus Estimate: ($1.08)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20206($1.84)($1.12)($1.38)
Q2 20206($1.84)($1.04)($1.33)
Q3 20207($1.52)($0.68)($0.97)
Q4 20207($1.52)($0.51)($0.85)
Q1 20215($0.84)($0.02)($0.46)
Q2 20215($0.75)$0.21($0.32)
Q3 20215($0.67)$0.26($0.21)
Q4 20214($0.55)$0.38($0.09)

Global Blood Therapeutics (NASDAQ GBT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/24/2021
(Estimated)
       
11/5/20209/30/2020($0.72)($0.97)($0.97)$44.56 million$37.00 millionTranscript
8/5/20206/30/2020($1.18)($0.86)($0.86)$18.85 million$31.50 millionTranscript
5/6/20203/31/2020($1.47)($1.20)($1.20)$3.65 million$14.12 millionTranscript
2/26/2020Q4 2019($1.24)($1.73)($1.87)$0.51 million$2.11 millionTranscript
11/7/2019Q3 2019($1.03)($1.07)($1.07)N/A
8/7/2019Q2 2019($0.9610)($1.01)($1.01)N/A
5/8/2019Q1($0.9430)($0.87)($0.87)N/A
2/27/2019Q4 2018($0.88)($0.93)($0.93)N/A
11/6/2018Q3($0.85)($0.83)($0.83)N/A
8/2/2018Q2 2018($0.87)($0.78)($0.78)N/A
5/7/2018Q1 2018($0.91)($0.87)($0.87)N/A
2/27/2018Q4 2017($0.7180)($0.94)($0.94)N/A
11/2/2017Q3 2017($0.62)($0.66)($0.66)N/A
8/7/2017Q2 2017($0.61)($0.55)($0.55)N/A
5/1/2017Q1 2017($0.71)($0.60)($0.60)N/A
3/13/2017Q4 2016($0.64)($0.74)($0.74)N/A
11/9/2016Q316($0.58)($0.58)($0.58)N/A
8/10/2016Q216($0.63)($0.58)($0.58)N/A
5/12/2016Q1($0.48)($0.56)($0.56)N/A
3/29/2016Q4($0.6350)($0.53)($0.53)N/A
11/12/2015Q3 2015($0.71)($0.90)($0.90)N/A
9/24/2015Q2 2015($4.04)($4.84)($4.84)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 11/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.